In conclusion, reserpine administration induces depressive and anxiety-like behaviors, increasing corticosterone and pro-inflammatory cytokines in the plasma and hippocampus, respectively, and decreasing hippocampal pCREB/BDNF expression. The gene discussed is BDNF; the disease is Anxiety.